Pure Global

HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia - Trial NCT06141655

Access comprehensive clinical trial information for NCT06141655 through Pure Global AI's free database. This Phase 4 trial is sponsored by Federico Martinón Torres and is currently Recruiting. The study focuses on Influenza. Target enrollment is 114011 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06141655
Phase 4
Recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06141655
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
Pragmatic Randomized Trial to Evaluate the Effectiveness of High-Dose Quadrivalent Influenza Vaccine vs. Standard-Dose Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia, Spain

Study Focus

Influenza

Influenza vaccine

Interventional

drug

Sponsor & Location

Federico Martinón Torres

Hospital Clinico Universitario de Santiago

Santiago de Compostela, Spain

Timeline & Enrollment

Phase 4

Oct 26, 2023

Aug 01, 2025

114011 participants

Primary Outcome

Occurrence of a hospitalization due to influenza or pneumonia

Summary

This pragmatic randomized trial is designed to evaluate the relative vaccine effectiveness of
 QIV-HD vs. QIV-SD in reducing the risk of hospitalization for influenza or pneumonia in
 adults 65-79 years of age in Galicia during 2023/2024 and 2024/2025 seasons.

ICD-10 Classifications

Influenza and pneumonia
Influenza due to identified seasonal influenza virus
Influenza with other manifestations, seasonal influenza virus identified
Influenza with pneumonia, seasonal influenza virus identified
Influenza due to identified zoonotic or pandemic influenza virus

Data Source

ClinicalTrials.gov

NCT06141655

Non-Device Trial